Risk factors for poor immune response to influenza vaccination in elderly people

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 4, 2006, Pages 269-273

  Bellei, Nancy C J ^a   Carraro, E ^a   Castelo, A ^a   Granato, C F H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dementia; Immune response; Influenza; Risk factors; Vaccination

Indexed keywords

CORTICOSTEROID; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

AGED; ANEMIA; ANTIBODY RESPONSE; ARTICLE; BRAZIL; CANDIDA; CANDIDIASIS; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CHRONIC LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; ELDERLY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HEMAGGLUTINATION INHIBITION TEST; HERPES; HERPES VIRUS; HUMAN; HYPOTHYROIDISM; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; NURSING HOME; RESPIRATORY TRACT INFECTION; RISK FACTOR; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; RISK FACTORS;

EID: 33947421266     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702006000400011     Document Type: Article

References (27)

1. Stamboulian D., Bonvehi P.E., Nacinovich F.M. Cox N. Influenza. Infect Dis Clin North Am 2000;14:141-66.
2. Deguchi Y., Takasugi Y. Efficacy of influenza vaccine in the elderly: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes. Int J Clin Lab Res 2000;30:1-4.
3. Vu T., Farish S., Jenkins M,. Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002;20:1831-6.
4. Cox N.J., Subbarao K. Influenza. Lancet 1999;354:1277-82.
5. Assessing adult vaccination status at age 50 years. MMWR Morb Mortal Wkly Rep 1995;44:561-3.
6. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., Malarkey W.B., Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 1996;93:3043-7.
7. Remarque E.J., Cools H.J., Boere T.J., et al. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. BMJ 1996;312:1015.
8. Vedhara K., Cox N.K., Wilcock G.K., et al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999;353:627-31.
9. de Bruijn I.A., Remarque E.J., Jol-van der Zijde C.M., et al. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 1999;179:31-6.
10. Govaert T.M., Thijs C.T., Masurel N., et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661-5.
11. Potter J.M., O'Donnel B., Carman W.F., Roberts M.A., Stott D.J. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Ageing 1999;28:141-5.
12. Powers D.C., Murphy B.R., Fries L.F., Adler W.H., Clements M.L. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. J Am Geriatr Soc 1992;40:163-7.
13. Remarque E.J. Influenza vaccination in elderly people. Exp Gerontol 1999;34:445-52.
14. de Jong J.C., Beyer W.E., Palache A.M., Rimmelzwaan G.F., Osterhaus A.D. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000;61:94-9.
15. Shinkawa M., Yanai M., Yamaya M., et al. Depressive state and common cold. Lancet 2000;356:942.
16. Shinkawa M., Nakayama K., Hirai H., et al. Depression and immunoreactivity in disabled older patients. J Am Geriatr Soc 2002;50:198-9.
17. Zadeh M.M., Buxton Bridges C., Thompson W.W., et al. Influenza outbreak detection and control measures in nursing homes in the United States. J Am Geriatr Soc 2000;48:1310-5.
18. Chavance M., Herbeth B., Fournier C., et al. Vitamin status, immunity and infections in an elderly population. Eur J Clin Nutr 1989;43:827-35.
19. Goodwin J.S., Garry P.J. Lack of correlation between indices of nutritional status and immunologic function in elderly humans. J Gerontol 1988;43:M46-9.
20. Pozzetto B., Odelin M.F., Bienvenu J., et al. Is there a relationship between malnutrition, inflammation, and post-vaccinal antibody response to influenza viruses in the elderly? J Med Virol 1993;41:39-43.
21. Chandra R.K., Puri S. Nutritional support improves antibody response to influenza virus vaccine in the elderly. BMJ 1985;291:705-6.
22. Chandra S., Chandra R.K. Nutrition, immune response, and outcome. Prog Food Nutr Sci 1986; 10:1-65.
23. Fulop T., Wagner J.R., Khalil A., et al. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol A Biol Sci Med Sci 1999;54:M59-64.
24. Bunout D., Barrera G., Hirsch S., et al. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J Parenter Enteral Nutr 2004;28:348-54.
25. Girodon F., Galan P., Monget A.L., et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999;159:748-54.
26. Bowles S.K., Lee W., Simor A.E., et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 2002;50:608-16.
27. Peters P.H., Gravenstein S., Norwood P., et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001;49:1025-31.